Geode Capital Management’s Immune Design Corp. IMDZ Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q2 | – | Sell |
-421,833
| Closed | -$2.47M | – | 4303 |
|
|
2019
Q1 | $2.47M | Buy |
421,833
+53,993
| +15% | +$184K | ﹤0.01% | 2728 |
|
|
2018
Q4 | $478K | Buy |
367,840
+15,925
| +5% | +$27.7K | ﹤0.01% | 3390 |
|
|
2018
Q3 | $1.21M | Buy |
351,915
+17,444
| +5% | +$65.5K | ﹤0.01% | 3135 |
|
|
2018
Q2 | $1.52M | Buy |
334,471
+47,440
| +17% | +$189K | ﹤0.01% | 3004 |
|
|
2018
Q1 | $947K | Buy |
287,031
+2,341
| +0.8% | +$8.29K | ﹤0.01% | 3146 |
|
|
2017
Q4 | $1.11M | Buy |
284,690
+161,168
| +130% | +$878K | ﹤0.01% | 3049 |
|
|
2017
Q3 | $1.28M | Buy |
123,522
+12,788
| +12% | +$126K | ﹤0.01% | 3011 |
|
|
2017
Q2 | $1.08M | Buy |
110,734
+7,436
| +7% | +$52.2K | ﹤0.01% | 3069 |
|
|
2017
Q1 | $702K | Buy |
103,298
+6,569
| +7% | +$38K | ﹤0.01% | 3178 |
|
|
2016
Q4 | $532K | Buy |
96,729
+5,633
| +6% | +$39.8K | ﹤0.01% | 3248 |
|
|
2016
Q3 | $690K | Buy |
91,096
+29,172
| +47% | +$213K | ﹤0.01% | 3126 |
|
|
2016
Q2 | $505K | Buy |
61,924
+540
| +0.9% | +$6.73K | ﹤0.01% | 3219 |
|
|
2016
Q1 | $797 | Buy |
61,384
+1,497
| +2% | +$17.3K | ﹤0.01% | 3004 |
|
|
2015
Q4 | $1.2M | Buy |
59,887
+2,092
| +4% | +$36K | ﹤0.01% | 2801 |
|
|
2015
Q3 | $705K | Buy |
57,795
+2,337
| +4% | +$43.8K | ﹤0.01% | 3064 |
|
|
2015
Q2 | $1.15M | Buy |
55,458
+20,830
| +60% | +$492K | ﹤0.01% | 2827 |
|
|
2015
Q1 | $730K | Buy |
34,628
+169
| +0.5% | +$4.41K | ﹤0.01% | 3026 |
|
|
2014
Q4 | $1.06M | Buy |
+34,459
| New | +$958K | ﹤0.01% | 2801 |
|
Geode Capital Management's IMDZ Position: Q2 2019 in Review
Geode Capital Management sold out of Immune Design Corp. (IMDZ) in Q2 2019, closing a stake of 421,833 shares — an estimated $2.47M sold.
Geode Capital Management first reported a position in IMDZ in Q4 2014 and held it in 18 quarters. The position peaked at $2.47M in Q1 2019. 0 funds tracked by Wall St. Rank hold IMDZ as of Q2 2019.
- Geode Capital Management reported no remaining Immune Design Corp. position as of Q2 2019 after selling out during the quarter.
- Geode Capital Management sold 421,833 Immune Design Corp. shares in Q2 2019, an estimated $2.47M.
- Geode Capital Management first reported a position in Immune Design Corp. in Q4 2014 and held it in 18 quarters.
- Geode Capital Management's Immune Design Corp. position peaked at $2.47M in Q1 2019.
- 0 funds tracked by Wall St. Rank held Immune Design Corp. as of Q2 2019.
Based on Geode Capital Management's 13F filing for Q2 2019, filed 14 Aug 2019.